Model Integration and Configuration for Stem Cell Therapy

Stem Cell Therapy Data Characteristics

Pharmacovigilance data for stem cell therapy originates primarily from clinical trial reports, real-world evidence (RWE), academic literature, and spontaneous reports from post-market surveillance systems. This data typically exists as unstructured text, including Case Report Forms (CRF), patient medical records, medical image interpretation reports, and investigator safety reports. Data updates frequently, especially during clinical trial phases. Document structures vary, lacking a unified standardized format. Data often contains medical terminology, abbreviations, dosage units (e.g., cells/kg, IU/mL), and treatment cycles (e.g., days, weeks, months) as specific fields. Adverse event descriptions are usually free text, covering event severity, onset time, outcome, and interventions.

Constraints Imposed by These Characteristics on Model Integration and Configuration

The highly unstructured and multi-source nature of stem cell therapy data demands robust data preprocessing capabilities from the model. Non-standardized document structures require stronger text parsing and information extraction abilities to identify key entities from free text, such as adverse event names, stem cell product names, dosages, administration routes, and times. Frequent data updates necessitate that the model quickly ingest new data and perform incremental learning or retraining to maintain timeliness. Unique medical terminology and measurement units, like CD34+ cell count or mg/kg, require the model to possess specialized domain knowledge to avoid information extraction errors due to misinterpreting terms. Furthermore, the complexity of adverse event descriptions, involving symptom descriptions, diagnostic results, and interventions, requires deeper semantic understanding from the model to accurately assess event correlation and severity.

Configuration Guidelines

Configuration Item	Recommended Value	Rationale
`maxContext`	`6000 tokens`	Ensures sufficient capacity to accommodate the full context of most adverse event reports, including patient basic information, treatment plans, and detailed event descriptions.
`Chunk size` (Segment Length)	`800–1200 characters` (characters)	Balances the average paragraph length in stem cell therapy reports, preventing key information dilution from excessively long segments or context loss from excessively short ones.
`Similarity threshold` (Similarity Threshold)	`0.78`	Increases the threshold for subtle semantic differences in medical texts, ensuring highly relevant document recall and reducing irrelevant information.
`Rerank result count` (Reranked Return Count)	`Top 5 entries` (top 5)	Pharmacovigilance analysis typically focuses on a few highly relevant, high-quality results. Too many results increase manual screening burden and reduce efficiency.
`Model Temperature (temperature)`	`0.3`	Reduces the randomness of model-generated results, ensuring more stable and accurate output when extracting factual information and performing classification, thereby reducing hallucinations.
`Entity Recognition Model Version`	`v2.1.0`	Ensures the use of a pre-trained model version that includes the latest stem cell products and related adverse reaction terminology to improve recognition accuracy.

Three Common Pitfalls

Key fields, such as adverse event severity or stem cell product batch number, are missing or empty in the structured data returned by the model. This typically occurs because text parsing rules are not robust enough to accurately identify specific fields within diverse document structures.
The model misunderstands medical terminology abbreviations, leading to incorrect adverse event classification or biased correlation judgments. This happens when the domain dictionary is not updated promptly, or the model lacks deep semantic understanding of the context.
Large model outputs for pharmacovigilance analysis reports have inconsistent formats, making automated downstream processing difficult. This indicates that constraints on output format in prompt design are not clear enough, or the model's ability to output in JSON or Markdown format is not fully utilized.

How to Confirm Proper Configuration

Select a test set containing typical adverse event reports. Verify if the model can accurately extract key fields such as adverse event name, onset time, and dosage. Compare these extractions with human annotations to confirm the accuracy rate of field extraction meets expectations.
Use test queries containing different stem cell products and various adverse reaction types. Check if the documents recalled by the model are highly relevant. Observe the similarity score distribution to confirm that the recall logic meets pharmacovigilance analysis requirements.
Submit queries containing complex medical terminology and abbreviations. Evaluate the model's understanding of these specialized terms. Check if the model's output explanations or classification results are accurate to verify the effectiveness of the domain knowledge base.

Note: The values provided are common starting points. Measure performance against specific samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.